Page last updated: 2024-10-24

chloroquine and Leukemia, Lymphoid

chloroquine has been researched along with Leukemia, Lymphoid in 7 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research Excerpts

ExcerptRelevanceReference
"The immunotoxin bound to all Burkitt's lymphoma cell lines that were tested but not to human peripheral blood T cells."1.27Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. ( Houston, LL; Ramakrishnan, S; Uckun, FM, 1985)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HIRAKI, K1
KIMURA, I1
Ramakrishnan, S3
Houston, LL3
Montag, H1
Schmeel, A1
Shirley, JA1
Eykyn, SJ1
Pearson, TC1
Laurent, G1
Pris, J1
Farcet, JP1
Carayon, P1
Blythman, H1
Casellas, P1
Poncelet, P1
Jansen, FK1
Uckun, FM2

Other Studies

7 other studies available for chloroquine and Leukemia, Lymphoid

ArticleYear
STUDIES ON THE TREATMENT OF MALIGNANT TUMORS WITH FIBROBLAST-INHIBITING AGENT. IV. EFFECTS OF CHLOROQUINE ON MALIGNANT LYMPHOMAS.
    Acta medicinae Okayama, 1964, Volume: 18

    Topics: Chloroquine; Fibroblasts; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphocytes; Lympho

1964
Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: potentiation by chloroquine.
    Science (New York, N.Y.), 1984, Jan-06, Volume: 223, Issue:4631

    Topics: Antibodies, Monoclonal; Cell Line; Chloroquine; Combined Modality Therapy; Dose-Response Relationshi

1984
[Porphyria cutanea tarda and chronic lymphatic leukemia].
    Zeitschrift fur Hautkrankheiten, 1984, Oct-15, Volume: 59, Issue:20

    Topics: Bloodletting; Chloroquine; Combined Modality Therapy; Humans; Leukemia, Lymphoid; Lymph Nodes; Male;

1984
Chloroquine-resistant falciparum malaria in a Bangladeshi girl with acute lymphoblastic leukaemia.
    British medical journal, 1979, Oct-06, Volume: 2, Issue:6194

    Topics: Acute Disease; Child; Chloroquine; Drug Resistance, Microbial; Female; Humans; Leukemia, Lymphoid; M

1979
Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patients.
    Blood, 1986, Volume: 67, Issue:6

    Topics: Adult; Antibodies, Monoclonal; Antibody Formation; Antigens, Differentiation, T-Lymphocyte; Antigens

1986
Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
    Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 134, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Binding Sites, Antibody; Bone Marrow; Bone

1985
Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein.
    Cancer research, 1985, Volume: 45, Issue:1

    Topics: Antibodies, Monoclonal; Antiviral Agents; B-Lymphocytes; Bone Marrow Cells; Cell Line; Cell Survival

1985